- 同
- CFTR
WordNet
- any of various controls or devices for regulating or controlling fluid flow, pressure, temperature, etc.
- an official responsible for control and supervision of a particular activity or area of public interest
- (genetics) a segment of DNA that is involved in producing a polypeptide chain; it can include regions preceding and following the coding DNA as well as introns between the exons; it is considered a unit of heredity; "genes were formerly called factors" (同)cistron, factor
- a materials capacity to conduct electricity; measured as the reciprocal of electrical resistance
- of or relating to or resembling a cyst
- of or relating to a normal cyst (as the gallbladder or urinary bladder)
- development of excess fibrous connective tissue in an organ
PrepTutorEJDIC
- 取り締まり人;調整者 / 調整装置
- 遺伝子
- (熱・電気などの)伝導度
- 胞嚢(ほうのう)性の
- 線維症(線維性結合線維が増殖し過ぎる症状)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A spatial model of fluid recycling in the airways of the lung.
- Sharp K1, Crampin E2, Sneyd J3.
- Journal of theoretical biology.J Theor Biol.2015 Oct 7;382:198-215. doi: 10.1016/j.jtbi.2015.06.050. Epub 2015 Jul 10.
- The genetic disease cystic fibrosis (CF) is a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, and results in viscous mucus and impaired mucociliary clearance leading to chronic recurring pulmonary infections. Although extensive experimental research has been conducte
- PMID 26169010
- Personalized medicine for cystic fibrosis: Establishing human model systems.
- Mou H1,2,3, Brazauskas K3, Rajagopal J1,2,4.
- Pediatric pulmonology.Pediatr Pulmonol.2015 Oct;50 Suppl 40:S14-23. doi: 10.1002/ppul.23233.
- With over 1,500 identifiable mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that result in distinct functional and phenotypical abnormalities, it is virtually impossible to perform randomized clinical trials to identify the best therapeutics for all patients. Theref
- PMID 26335952
- Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
- Solomon GM1, Marshall SG2, Ramsey BW2,3, Rowe SM1,4.
- Pediatric pulmonology.Pediatr Pulmonol.2015 Oct;50 Suppl 40:S3-S13. doi: 10.1002/ppul.23240. Epub 2015 Jun 19.
- Cystic Fibrosis is caused by mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene resulting in abnormal protein function. Recent advances of targeted molecular therapies and high throughput screening have resulted in multiple drug therapies that target many important muta
- PMID 26097168
Japanese Journal
- のう胞性線維症におけるトランスレーショナルリサーチ
- Protective Role of Cardiac CFTR Activation Upon Early Reperfusion Against Myocardial Infarction
- Distal intestinal obstruction syndromeを認めた嚢胞性線維症の1例
Related Links
- The CFTR gene provides instructions for making a protein called the cystic fibrosis transmembrane conductance regulator. This protein functions as a channel across the membrane of cells that produce mucus, sweat ...
- The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene was identified in 1989 by geneticist Lap-Chee Tsui and his research team as the gene associated with cystic fibrosis (CF). Tsui’s research pinpointed the ...
★リンクテーブル★
[★]
- 英
- cystic fibrosis transmembrane conductance regulator gene
[★]
- 関
- permeability、permeabilize、permeable
[★]
- 関
- membrane-spanning、TM、transmembranous
[★]
- 関
- regulatory factor
[★]
- 関
- membrane conductance
[★]
- 関
- regulatory gene